Streetbeat News

CRLBF

Cresco Labs Inc.

http://www.crescolabs.com/

CEO

Charles Bachtell

Employees

3,500

Industry

Medicinal and Botanical Manufacturing

Open

0.73

Mkt cap

330M

Volume

60K

High

0.75

P/E Ratio

-4.35

52-wk high

2.60

Low

0.73

Div yield

N/A

52-wk low

0.70

Cresco Labs Inc. (CRLBF) reported a Q4 loss of $0.01 per share, matching the Zacks Consensus Estimate, but showed improvement in revenue, surpassing expectations.

Portfolio Pulse from

March 14, 2025 | 10:30 pm

Cresco Labs Inc. held its Q4 2024 earnings call, discussing financial results and company developments. Key participants included CEO Charles Bachtell and CFO Sharon Schuler.

Portfolio Pulse from

March 12, 2025 | 3:00 pm

The marijuana stock market is influenced by legal operators and regulatory changes. Improved laws could stabilize the market, which has been volatile since cannabis legalization in the US.

Portfolio Pulse from

March 10, 2025 | 1:30 pm

The U.S. cannabis industry is evolving with significant growth expected. Investors are focusing on Cresco Labs Inc. (CRLBF), Verano Holdings Corp. (VRNOF), and Curaleaf Holdings, Inc. (CURLF) due to their strong market presence and financial performance.

Portfolio Pulse from

March 09, 2025 | 3:15 pm

Cresco Labs is set to report its fourth quarter 2024 financial results on March 12, 2025. This announcement is crucial for investors to assess the company's performance and future prospects.

Portfolio Pulse from

March 03, 2025 | 11:45 am

The US cannabis industry is poised for growth with projected sales of $40 billion by 2025. Federal rescheduling efforts, including a recommendation by HHS to reclassify cannabis as a Schedule III substance, could enhance industry prospects. Investors are monitoring top marijuana stocks for potential gains.

Portfolio Pulse from

February 04, 2025 | 3:15 pm

The marijuana industry is poised for significant developments in 2025, with potential legalization in remaining US states and the introduction of cannabis lounges. These changes could boost the market and drive reform.

Portfolio Pulse from

January 06, 2025 | 2:30 pm

The US cannabis industry is experiencing significant growth, with the market expected to grow from $33 billion in 2024 to over $60 billion by 2030. This growth is driven by state-level legalization, medical program development, and potential federal policy reforms like the SAFE Banking Act, which could enhance banking access for cannabis companies.

Portfolio Pulse from

December 31, 2024 | 3:15 pm

The US cannabis industry is poised for growth with a projected market value over $40 billion by 2025. Companies like Trulieve, Cresco Labs, and Verano Holdings are key players. Federal legalization discussions could further boost the sector.

Portfolio Pulse from

December 24, 2024 | 3:15 pm

The US cannabis sector has seen a recent pullback due to market volatility and regulatory concerns, creating potential buying opportunities for undervalued stocks. Despite short-term challenges, the long-term outlook remains positive, with the market expected to exceed $41 billion by 2025.

Portfolio Pulse from

December 12, 2024 | 3:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.